Infield et al., 2023 - Google Patents
Real-time observation of functional specialization among phosphorylation sites in CFTRInfield et al., 2023
View HTML- Document ID
- 12915754638645165423
- Author
- Infield D
- Schene M
- Fazan F
- Galles G
- Galpin J
- Ahern C
- Publication year
- Publication venue
- Journal of General Physiology
External Links
Snippet
Phosphoregulation is ubiquitous in biology. Defining the functional roles of individual phosphorylation sites within a multivalent system remains particularly challenging. We have therefore applied a chemical biology approach to light-control the state of single candidate …
- 238000006366 phosphorylation reaction 0 title abstract description 90
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nishiyama et al. | Two distinct modes of DNMT1 recruitment ensure stable maintenance DNA methylation | |
Kleiner et al. | Chemical proteomics reveals a γH2AX-53BP1 interaction in the DNA damage response | |
Milojević et al. | The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor | |
Tanzer et al. | Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop | |
Pandey et al. | Calcium/calmodulin-dependent kinase II mediates the phosphorylation and activation of NADPH oxidase 5 | |
Abramian et al. | Protein kinase C phosphorylation regulates membrane insertion of GABAA receptor subtypes that mediate tonic inhibition | |
Barbagallo et al. | Genetically encoded biosensors reveal PKA hyperphosphorylation on the myofilaments in rabbit heart failure | |
Long et al. | Akt3 is a privileged first responder in isozyme-specific electrophile response | |
Infield et al. | Real-time observation of functional specialization among phosphorylation sites in CFTR | |
Barreira et al. | The C-terminal SH3 domain contributes to the intramolecular inhibition of Vav family proteins | |
Guttman et al. | Interactions of the NPXY microdomains of the low density lipoprotein receptor‐related protein 1 | |
Hwang et al. | Extracellular signal-regulated kinase 2-dependent phosphorylation induces cytoplasmic localization and degradation of p21Cip1 | |
Graeser et al. | Regulation of the CDK-related protein kinase PCTAIRE-1 and its possible role in neurite outgrowth in Neuro-2A cells | |
Kalia et al. | PSD‐95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex | |
Deng et al. | Molecular basis for N-terminal acetylation by human NatE and its modulation by HYPK | |
Hiiragi et al. | Transglutaminase type 1 and its cross-linking activity are concentrated at adherens junctions in simple epithelial cells | |
Chou et al. | GABAA receptor trafficking is regulated by protein kinase Cε and the N-ethylmaleimide-sensitive factor | |
Gustafsson et al. | Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54) | |
Li et al. | Three Ubiquitination Sites of Organic Anion Transporter-1 Synergistically Mediate Protein Kinase C–Dependent Endocytosis of the Transporter | |
Fuhs et al. | Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization | |
Büchse et al. | CIN85 interacting proteins in B cells-specific role for SHIP-1 | |
Denton et al. | Calcium-insensitive splice variants of mammalian E1 subunit of 2-oxoglutarate dehydrogenase complex with tissue-specific patterns of expression | |
Keshwani et al. | Nuclear protein kinase CLK1 uses a non-traditional docking mechanism to select physiological substrates | |
Hammelmann et al. | The cGMP-dependent protein kinase II Is an inhibitory modulator of the hyperpolarization-activated HCN2 channel | |
Schmoker et al. | Dynamic multi-site phosphorylation by Fyn and Abl drives the interaction between CRKL and the novel scaffolding receptors DCBLD1 and DCBLD2 |